glp-1 and beta blockers Glucagon-like peptide-1 Glucagon-like peptide-1 receptor: mechanisms and

For example, people with diabetes and PAD have a fivefold increased risk of amputation and a threefold increased risk of death relative to their non-diabetic counterparts [5]

When we lack nutrients, we experience cravings and food noise

What good monitoring looks like Routine follow-up with your diabetes doctor Retinal monitoring based on your baseline eye disease severity Faster eye review if symptoms appear or worsen Coordination between endocrinology and ophthalmology if retinopathy is active For some patients, this may mean standard annual follow-up

Personalized medicine: Given the individual variability in response to GLP-1 agonists, personalized treatment plans are becoming increasingly important

It is good to have regular check-ups and talk openly with your healthcare provider about your health, which can help lower the risk of problems

London: CoSRH (2024)